How Research Peptides Are Manufactured in the USA (Step by Step)
From resin to vial: solid-phase peptide manufacturing, HPLC purification, lyophilization, and QC — how a research peptide is actually made.
By PX1 Research Team · July 18, 2026
Step 1: Solid-phase peptide manufacturing (SPPS)
Every modern research peptide is built one amino acid at a time on a solid resin, using Fmoc chemistry:
- The first amino acid is anchored to a polystyrene or PEG resin.
- The Fmoc protecting group is removed with piperidine.
- The next amino acid — protected on its α-amine — is coupled using an activator (HBTU, HATU, or DIC/Oxyma).
- Wash, deprotect, and repeat until the full sequence is assembled.
A 30-residue peptide takes ~60 coupling cycles and 1–3 days on an automated manufacturer.
Step 2: Cleavage
The completed peptide is cleaved from the resin — and side-chain protecting groups are removed — with a strong-acid cocktail (typically TFA with water, TIS, and thiol scavengers) for 2–4 hours. The peptide is then precipitated in cold diethyl ether.
Step 3: Preparative HPLC purification
The crude peptide is redissolved and injected onto a preparative reversed-phase HPLC column (large-scale C18) with an acetonitrile/water/TFA gradient. Truncated sequences, deletion products, and byproducts elute at different retention times; only the target peak is collected.
This is where purity is made. Sloppy manufacturing can be rescued with aggressive HPLC; sloppy HPLC can't be rescued at all.
Step 4: Lyophilization
The purified peptide fractions are pooled, frozen in shell trays, and freeze-dried under vacuum. Residual water drops to <3–5%. The result is a fluffy white powder.
Lyophilization matters more than most buyers realize: under-dried powder is chemically unstable, hygroscopic, and short-shelf-life.
Step 5: Vialing and stoppering
The lyophilized powder is dispensed into vials — usually 5 mL or 10 mL amber glass — in a controlled environment. Vials are stoppered, crimped, and labeled with lot number, mass, and manufacture date.
Step 6: Analytical QC
A sample from each lot goes through the full analytical panel:
- HPLC purity at 214 nm.
- LC-MS identity confirming the observed mass matches theory.
- Karl Fischer moisture.
- Endotoxin (LAL or rFC).
- Sterility.
- Residual solvents by GC.
The COA is issued only when every result is in spec.
Step 7: Release and shipping
Approved lots enter inventory. Rejected lots don't leave the facility. Shipping is room-temperature for lyophilized product — no cold-chain required.
See PX1's manufacturing details and facility photos at /manufacturing-process.
PX1 Research Team
PX1 Research is a primary US cGMP-compliant peptide manufacturer. Our team handles solid-phase synthesis, HPLC purification, lyophilization and in-house analytical testing — every batch ships with a lot-specific Certificate of Analysis.
See how we manufacture